What Is Peyote? The Hallucinogenic Cactus Explained

Peyote is a small, spineless cactus native to the deserts of northern Mexico and southern Texas, and it is one of the oldest known hallucinogenic plants used by humans. Its scientific name is Lophophora williamsii, and it produces mescaline, the psychoactive compound responsible for its vivid visual and psychological effects. Archaeological specimens with confirmed mescaline content have been radiocarbon-dated to roughly 5,700 years ago, making peyote use among the longest continuous relationships between a human culture and a psychoactive plant.

What the Cactus Looks Like and Where It Grows

Peyote does not look like what most people picture when they think of a cactus. It is small, rarely more than a few centimeters tall above ground, with a rounded, blue-green top that sits almost flush with the desert soil. It has no spines. Instead, it grows tufts of soft, white hair from raised bumps called areoles arranged in a distinctive pattern. The visible portion above ground is sometimes called a “button” or “crown,” while the bulk of the plant is a thick, carrot-shaped taproot hidden beneath the surface.

Its native range runs through the Chihuahuan Desert and the Tamaulipan thornscrub of southern Texas and northeastern Mexico. Peyote tends to grow in limestone soils, often partially shaded by shrubs or low desert trees. It is an extremely slow-growing species, taking up to ten years to mature from seed to a size large enough to harvest, which is not unusual for cacti but has serious implications for the plant’s long-term survival.

The Alkaloids Inside Peyote

Mescaline gets almost all the attention, but peyote contains a cocktail of biologically active alkaloids. These include pellotine, anhalonidine, and hordenine, among others.¹ Researchers have identified dozens of alkaloids in the plant, though mescaline is the one primarily responsible for peyote’s hallucinogenic properties. The others may contribute subtle effects or interact with mescaline in ways that are not yet fully understood, but they are pharmacologically distinct compounds in their own right.

One reason the full chemistry of peyote has been slow to unravel is that the plant’s biosynthetic pathway for producing mescaline was not fully mapped until very recently. Two independent research groups published near-complete descriptions of the pathway in 2023 and 2024, showing that the cactus builds mescaline from the amino acid tyrosine through a series of enzymatic steps. A key finding was the identification of specific enzymes, including a cytochrome P450 and several O-methyltransferases, that carry out these transformations in sequence.² A separate team also identified an N-methyltransferase enzyme that modifies the intermediates in the pathway, likely helping the plant regulate how much mescaline it ultimately produces.³

Knowing the complete biosynthetic route matters beyond pure chemistry. It opens the door to producing mescaline in laboratory organisms like yeast or bacteria rather than harvesting it from wild or cultivated peyote. That prospect is relevant for both pharmaceutical research and conservation, since wild peyote populations are under increasing pressure.

How Mescaline Works in the Brain

Mescaline belongs to the phenethylamine class of psychedelics, chemically distinct from tryptamine-based psychedelics like psilocybin or DMT. Despite this structural difference, it acts on the same primary target in the brain: the serotonin 5-HT2A receptor. Activation of this receptor is the main driver of mescaline’s hallucinogenic effects, including visual distortions, changes in perception of time, and altered emotional states.⁴ The 5-HT2C receptor also plays a role, though it appears to contribute less to the overall experience.

What makes mescaline unusual among psychedelics is its duration and dose profile. A typical mescaline experience lasts roughly eight to twelve hours, which is considerably longer than psilocybin (four to six hours) but comparable to LSD. The dose required to produce full psychedelic effects is also much higher in absolute milligram terms than for most other psychedelics, which partly explains why consuming peyote traditionally involves eating a relatively large amount of dried cactus material, often described as bitter and difficult to keep down.

What the Experience Feels Like

Survey data from people who have used mescaline paints a relatively consistent picture. In a large survey published in the Journal of Psychopharmacology, respondents rated acute mystical-type effects as “moderate,” ego-dissolution and psychological insight as “slight,” and challenging or difficult effects as “very slight.”⁵ In other words, mescaline tends to produce a gentler, more grounded experience than some other classical psychedelics. Users commonly describe vivid color enhancement, geometric visual patterns, a feeling of emotional openness, and a heightened sense of connection to surroundings.

That said, “very slight” challenging effects is a group average, not a guarantee for any individual. Set and setting, the psychological state you bring and the physical environment you are in, profoundly shape psychedelic experiences. Nausea is also common in the early phase of a peyote experience, largely due to the other alkaloids and plant material rather than mescaline itself. Traditional ceremonial use typically involves specific rituals, songs, and a structured social context that can significantly influence the quality and character of the experience.

Thousands of Years of Human Use

The archaeological record for peyote is remarkably deep. Dried peyote buttons recovered from rock shelters in the Lower Pecos region of Texas were radiocarbon-dated to approximately 3780–3660 BC, with mescaline confirmed to still be present in the specimens after nearly six millennia.⁶ A subsequent study pushed the confirmed timeline even further back, dating specimens from the Shumla Caves to roughly 6,000 calendar years ago, and confirming Late Prehistoric use in the Cuatro Ciénegas region of Mexico as well.⁷

The use of peyote by Indigenous peoples of Mexico and the American Southwest continued without interruption through these millennia. The Huichol (Wixárika) of western Mexico have one of the best-documented peyote traditions, involving long pilgrimages to the desert where peyote grows naturally. In the late 19th century, peyote use spread northward among Native American communities in the United States, eventually becoming central to the Native American Church, which was formally incorporated in 1918 and currently has an estimated 250,000 to 400,000 members. The church’s ceremonies use peyote as a sacrament, combining Indigenous spiritual practices with elements of Christianity.

Federal law in the United States reflects this history in a patchwork way. Mescaline is classified as a Schedule I controlled substance, making it illegal for the general population. However, the American Indian Religious Freedom Act Amendments of 1994 provide a specific exemption for the use of peyote in bona fide Native American Church ceremonies by enrolled members of federally recognized tribes. This creates an unusual legal situation where the same substance is fully prohibited for most Americans and constitutionally protected for others.

Conservation and Harvesting Pressures

Peyote is in trouble in the wild. Its native range in the United States is limited to a few counties in southern Texas, and the populations there face multiple simultaneous threats. Habitat conversion for ranching, agriculture, urban development, and energy infrastructure has steadily reduced the land where peyote grows. Legal harvesting for the Native American Church accounts for substantial collection, and illegal poaching adds further pressure. The combined impact of these threats has never been formally quantified, but field researchers have documented population declines across the plant’s Texas range.⁸

The plant’s biology makes these pressures especially dangerous. With a maturation period of up to ten years from seed to harvestable size, peyote cannot quickly bounce back from overharvesting. Even when harvesting is done with optimal technique, cutting just the crown and leaving the root intact, experimental studies show it takes at least six to eight years for the cactus to regenerate a new crown. And that best-case scenario assumes the harvester cuts correctly. Research on mescaline distribution within the plant found that non-traditional harvesting methods that cut into non-green tissue below the crown contribute to plant death and failure to regenerate.⁹ In other words, the way the cactus is harvested is nearly as important as how much is taken.

This conservation situation has generated tension between the religious needs of the Native American Church, which depends on a supply of wild peyote, and the ecological reality that wild populations appear to be shrinking. Some advocates have called for cultivation programs or the expansion of legal protections for peyote habitat, but progress has been slow. The plant’s legal status itself complicates conservation efforts, since research permits and cultivation are tightly restricted.

San Pedro and Other Mescaline-Containing Cacti

Peyote is not the only cactus that produces mescaline. The San Pedro cactus (Trichocereus pachanoi) and the closely related Peruvian torch (Trichocereus peruvianus) are tall, columnar cacti native to the Andes that also contain mescaline and have their own long history of ceremonial use in South America. A third species, Trichocereus bridgesii, is widely used as well. Unlike peyote, these cacti grow quickly, reaching harvestable size in a fraction of the time, which makes them far more sustainable as a source of mescaline.

Survey data comparing people who prefer peyote versus San Pedro found that the motivations for choosing one over the other are telling. Among those who preferred peyote, the most commonly cited reasons were Indigenous cultural traditions, availability, and environmental sustainability. Among San Pedro users, availability and potency ranked highest.¹⁰ San Pedro was the most commonly reported source of mescaline product consumed overall, reflecting both its faster growth rate and its wider legal availability. In many countries, San Pedro cacti can be legally purchased as ornamental plants, even though extracting mescaline from them remains illegal.

The existence of faster-growing mescaline-producing cacti is sometimes offered as a potential conservation solution for peyote. If people seeking mescaline for non-ceremonial purposes shifted entirely to cultivated San Pedro, harvesting pressure on wild peyote could ease. The Native American Church, however, has specifically opposed efforts to substitute other cacti or synthetic mescaline for peyote in their ceremonies, viewing the peyote cactus itself as sacred rather than simply a vehicle for a chemical compound.

Early Therapeutic Research

Mescaline is drawing renewed attention from researchers studying psychedelics as potential treatments for psychiatric conditions. This is part of a broader revival of psychedelic science, but mescaline has historically received far less clinical attention than psilocybin or LSD. That gap is now beginning to close.

A large survey-based study found that among respondents who reported histories of depression, anxiety, PTSD, or substance use disorders, most (between 68% and 86% depending on the condition) reported subjective improvement following what they considered their most memorable mescaline experience. The experience of psychological insight during the session was specifically associated with higher odds of reporting improvement in depression, anxiety, and substance use problems.¹¹ These are self-reported, retrospective findings rather than clinical trial results, so they cannot establish that mescaline caused the improvements. But the numbers are strong enough to justify controlled research.

Formal clinical trials are now underway. Researchers studying the safety pharmacology of mescaline in healthy participants are laying the groundwork that regulatory agencies require before therapeutic trials can proceed.¹² Mescaline’s long duration and distinct pharmacological profile compared to psilocybin raise the question of whether it might offer therapeutic advantages for certain conditions, or whether its longer time commitment makes it less practical in clinical settings. Those are open questions that the current generation of trials aims to answer.

One complication for mescaline research is political. Some Indigenous leaders and organizations have expressed concern that medicalizing mescaline could increase demand for peyote, worsening the conservation situation for wild populations. Others worry that commercialization would commodify a sacred plant. Several psychedelic research organizations have publicly stated that they intend to use synthetic mescaline rather than plant-derived material for clinical work, partly to address these concerns.

Why Does a Cactus Make Hallucinogens at All?

From the plant’s perspective, mescaline almost certainly has nothing to do with inducing spiritual experiences in humans. The leading scientific hypothesis is that mescaline and related alkaloids evolved as chemical defenses against herbivores. A 2025 paper integrating chemical ecology with evolutionary biology proposed that natural hallucinogens across multiple species, including mescaline in cacti and psilocybin in fungi, likely function as defensive agents that deter animals from eating the organism, or as compounds that manipulate the behavior of herbivores and pollinators in ways that benefit the plant.¹³

The fact that mescaline targets serotonin receptors in the mammalian brain may be a side effect of its ecological function rather than its purpose. Serotonin signaling is ancient and conserved across the animal kingdom, so a chemical that disrupts serotonin-mediated behavior in desert rodents or insects would likely also have psychoactive effects in humans. The convergent evolution of similar compounds in unrelated lineages, cacti producing mescaline, mushrooms producing psilocybin, and grasses harboring ergot alkaloids, suggests that the defensive strategy of targeting these neural pathways has been independently “discovered” by evolution multiple times. The fact that humans find these effects interesting, meaningful, or even sacred is an evolutionary accident that the cactus never planned for.

Physical Risks and Safety Considerations

Mescaline has a relatively favorable acute safety profile compared to many recreational drugs. It does not produce physical dependence, and lethal overdoses from peyote or mescaline are essentially unheard of in the medical literature. The most common physical side effects during a peyote experience are nausea, vomiting, increased heart rate, and elevated blood pressure. For most healthy individuals, these effects are uncomfortable but not dangerous. However, people with serious cardiovascular conditions should treat any substance that raises heart rate and blood pressure with caution.

The psychological risks are more relevant. Like all classical psychedelics, mescaline can produce intensely distressing experiences, sometimes called “bad trips,” particularly in unsupported settings or in people with a personal or family history of psychotic disorders. While the survey data discussed earlier reported challenging effects as generally slight on average, individual experiences vary widely. Psychological screening is standard practice in clinical psychedelic research precisely because a small fraction of people are vulnerable to prolonged adverse psychological reactions.

There is also the practical matter of misidentification. Peyote’s small, ground-level growth habit makes it easy to confuse with other small cacti, some of which contain different and potentially harmful alkaloids. Related “peyote” cacti in other genera, such as Pelecyphora aselliformis, contain overlapping but not identical alkaloid profiles.¹⁴ The alkaloid overlap is interesting from a botanical standpoint but means that someone unfamiliar with desert cactus identification could easily collect the wrong species, with unpredictable consequences.